nivolumab,ipilimumab
bms
['s1609']
awesome and clear presentation by s #meganothus (statistician extraordinaire!) describing our work on using continuous tumor size measurements as prediction for patient benefit on a large, tumor-agnostic population from #dart trial (s1609). 
#MedicalOncologist tweeting on #immunotherapy, #drugdevelopment, #COVID19 & #HealthEcon. #NCI #CancerMoonshot Adult Immunotherapy Co-Chair. Tweets are mine.